Professional societies of neurologists, including most prominently the American Academy of Neurology (AAN) and the European Academy of Neurology (EAN) periodically release recommendations to guide ...

Medical experts discuss the failure of evobrutinib to meet its primary endpoint in phase 3 trials, review the primary outcomes of the phase 2B study of tolebrutinib in relapsing multiple sclerosis, ...

Imaging is a crucial tool in the diagnosis of MS. Magnetic resonance imaging (MRI) reveals multiple demyelinated lesions scattered throughout the CNS, marked by inflammation, edema, glial reaction and ...

—A case-control study from Sweden examined familial risk and heritability of MS through 2 major phenotypes: relapsing onset and primary progressive. Do certain genetic effects increase the risk for ...

Multiple sclerosis occurs when a person’s immune system is triggered to attack the myelin sheath—a protective coating surrounding nerve cells in the central nervous system (CNS). The CNS is made up of ...

In a study of commonly used treatments for multiple sclerosis, both medical and behavioral interventions, and a combination of the two, resulted in significant improvements in fatigue. Researchers say ...

Pheno Therapeutics Limited., a biotechnology company focused on the discovery and development of small molecule therapeutics for the treatment of neurological diseases, announced today it has received ...